Position in AZN
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$401,994
-$395,366 QoQ
Shares Held
2,120
-47.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#933
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gallacher Capital Management LLC holds $3,790,927 across 9 Drug Manufacturers - General names. AZN ranks #6 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
532 | $638,096 | |
| 2 | NVS |
Novartis AG
|
3,514 | $550,714 | |
| 3 | NVO |
Novo Nordisk A S
|
11,461 | $549,440 | |
| 4 | JNJ |
Johnson & Johnson
|
1,733 | $440,130 | |
| 5 | GSK |
GSK plc
|
8,312 | $435,715 | |
| 6 | AZN |
Astrazeneca PLC
This page
|
2,120 | $401,994 | |
| 7 | AMGN |
Amgen Inc
|
797 | $288,609 | |
| 8 | SNY |
Sanofi
|
6,375 | $271,957 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $401,994 | 2,120 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $797,360 | 4,043 | Shares | Sole | 2026-05-06 | |
| No filing history on record for this holder in this stock. | ||||||